The use of drug transporters as therapeutic targets. Read more about The use of drug transporters as therapeutic targets.
Highlights in breast cancer from the 2016 American Society of Clinical Oncology Annual Meeting. Read more about Highlights in breast cancer from the 2016 American Society of Clinical Oncology Annual Meeting.
The use of ibrutinib in chronic lymphocytic leukemia. Read more about The use of ibrutinib in chronic lymphocytic leukemia.
The value and effectiveness of angiogenesis inhibitors for colorectal cancer. Read more about The value and effectiveness of angiogenesis inhibitors for colorectal cancer.
New and emerging therapeutic options for the management of chemotherapy-induced nausea and vomiting. Read more about New and emerging therapeutic options for the management of chemotherapy-induced nausea and vomiting.
Bevacizumab vs EGFR antibodies in metastatic colorectal cancer. Read more about Bevacizumab vs EGFR antibodies in metastatic colorectal cancer.
Evidence-driven, patient-specific approaches for optimizing survival prolongation in breast cancer. Read more about Evidence-driven, patient-specific approaches for optimizing survival prolongation in breast cancer.
Management of chemotherapy-induced nausea and vomiting in clinical practice. Read more about Management of chemotherapy-induced nausea and vomiting in clinical practice.
Clinical roundtable monograph: New data in emerging treatment options for chemotherapy-induced nausea and vomiting. Read more about Clinical roundtable monograph: New data in emerging treatment options for chemotherapy-induced nausea and vomiting.
